References
1. Lip GY, Fauchier L, Freedman SB, Van Gelder I, Natale A, Gianni C, et
al. Atrial fibrillation. Nature reviews Disease primers. 2016;2:16016.
2. Piccini JP, Hammill BG, Sinner MF, Jensen PN, Hernandez AF, Heckbert
SR, et al. Incidence and prevalence of atrial fibrillation and
associated mortality among Medicare beneficiaries, 1993-2007.
Circulation Cardiovascular quality and outcomes. 2012;5(1):85-93.
3. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of
current and future incidence and prevalence of atrial fibrillation in
the U.S. adult population. The American journal of cardiology.
2013;112(8):1142-7.
4. Tu K, Nieuwlaat R, Cheng SY, Wing L, Ivers N, Atzema CL, et al.
Identifying Patients With Atrial Fibrillation in Administrative Data.
The Canadian journal of cardiology. 2016;32(12):1561-5.
5. Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R, Dublin S. A
systematic review of validated methods for identifying atrial
fibrillation using administrative data. Pharmacoepidemiology and drug
safety. 2012;21 Suppl 1:141-7.
6. Kleinbaum DG, Kupper L, Morgenstern H. Epidemiologic research.
Principles and quantitative methods. Van Nostrand Reinhold: New York
City, NY, USA. 1982.
7. Statistical-Analysis-Software. Base SAS 9.4 procedures guide:
statistical procedures, 2nd Edition. SAS, 2013: Cary, NC, USA. 2013.
8. CDC. Division for Heart Disease and Stroke Prevention. Atrial
fibrillation fact sheet. Reported in https://
www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_atrial_fibrillation.htm.
Page last reviewed: Aug 22, 2017. 2017.
9. Ohlmeier C, Mikolajczyk R, Haverkamp W, Garbe E. Incidence,
prevalence, and antithrombotic management of atrial fibrillation in
elderly Germans. Europace : European pacing, arrhythmias, and cardiac
electrophysiology : journal of the working groups on cardiac pacing,
arrhythmias, and cardiac cellular electrophysiology of the European
Society of Cardiology. 2013;15(10):1436-44.
10. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of
atrial fibrillation: European perspective. Clinical epidemiology.
2014;6:213-20.
11. Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, et
al. Incidence and prevalence of atrial fibrillation: an analysis based
on 8.3 million patients. Europace : European pacing, arrhythmias, and
cardiac electrophysiology : journal of the working groups on cardiac
pacing, arrhythmias, and cardiac cellular electrophysiology of the
European Society of Cardiology. 2013;15(4):486-93.
12. Johansson C, Hagg L, Johansson L, Jansson JH. Characterization of
patients with atrial fibrillation not treated with oral anticoagulants.
Scandinavian journal of primary health care. 2014;32(4):226-31.
13. Cowan C, Healicon R, Robson I, Long WR, Barrett J, Fay M, et al. The
use of anticoagulants in the management of atrial fibrillation among
general practices in England. Heart (British Cardiac Society).
2013;99(16):1166-72.
14. Shaikh F, Pasch LB, Newton PJ, Bajorek BV, Ferguson C. Addressing
Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation.
Current cardiology reports. 2018;20(5):32.
15. Lip GYH. The ABC pathway: an integrated approach to improve AF
management. Nature reviews Cardiology. 2017;14(11):627-8.
16. Yoon M, Yang PS, Jang E, Yu HT, Kim TH, Uhm JS, et al. Improved
Population-Based Clinical Outcomes of Patients with Atrial Fibrillation
by Compliance with the Simple ABC (Atrial Fibrillation Better Care)
Pathway for Integrated Care Management: A Nationwide Cohort Study.
Thrombosis and haemostasis. 2019;19(10):1695-703.
17. Pastori D, Pignatelli P, Menichelli D, Violi F, Lip GYH. Integrated
Care Management of Patients With Atrial Fibrillation and Risk of
Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway
in the ATHERO-AF Study Cohort. Mayo Clinic proceedings.
2019;94(7):1261-7.
18. Guo Y, Lane DA, Wang L, Zhang H, Wang H, Zhang W, et al. Mobile
Health Technology to Improve Care for Patients With Atrial Fibrillation.
Journal of the American College of Cardiology. 2020;75:1523-34.